Evidence map›Paper›PMID 41216209›Full record

ReviewBreast cancer (Dove Medical Press)2025

Demonstrating the Absence of Correlation Between Molecular Docking and in vitro Cytotoxicity in Anti-Breast Cancer Research: Root Causes and Practical Resolutions.

Sandra Megantara, Agus Rusdin, Arif Budiman, Lisa Efriani Puluhulawa, Nur Kusaira Binti Khairul Ikram, Muchtaridi Muchtaridi

Abstract readReview
In one paragraph

Review in Breast cancer (Dove Medical Press), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sandra MegantaraDepartment of Pharmacy Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.ORCID 0000-0003-4951-7740
Agus RusdinDepartment of Pharmaceutical and Technology Pharmaceutics, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
Arif BudimanDepartment of Pharmaceutical and Technology Pharmaceutics, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
Lisa Efriani PuluhulawaDepartment Pharmacy, Faculty Sport and Health, Universitas Negeri Gorontalo, Gorontalo, 96128, Indonesia.
Nur Kusaira Binti Khairul IkramInstitute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Muchtaridi MuchtaridiDepartment of Pharmacy Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.ORCID 0000-0002-6156-8025

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In silico methods have significantly transformed the landscape of drug discovery by enabling rapid and cost-effective screening of prospective therapeutic compounds. However, these computational techniques remain limited in their ability to fully predict complex biological behavior, particularly within the constraints of quantum level interactions and simplified receptor-ligand models. As such, validation through experimental data remains critical. Purpose: This review aims to critically evaluate the correlation between molecular docking predictions specifically Gibbs free energy (ΔG) and in vitro cytotoxicity data (IC Methodology: A structured methodology was employed, applying predefined inclusion and exclusion criteria to identify studies reporting both in silico molecular docking results and in vitro cytotoxicity data on the MCF-7 cell line, with a focus on compounds targeting breast cancer-related proteins. Results: Findings demonstrated that, contrary to theoretical expectations, no consistent linear correlation was observed between ΔG values and IC Conclusion: This review underscores the need to move beyond single parameter docking predictions and adopt integrated strategies that combine computational models with empirical validations. Future studies should emphasize the use of standardized in vitro conditions, rational target selection, and complementary techniques such as molecular dynamics simulations, intracellular exposure assessment, and target engagement validation. These integrative approaches will enhance the predictive power of in silico methods and foster a more reliable foundation for anti-breast cancer drug development.

Indexed as

anti-breast cancer drug discoveryGibbs free energyin vitro cytotoxicityMCF-7 cell linemolecular docking

Identifiers

PMID41216209
PMCPMC12596839

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.